Skip to main content
. 2013 May 23;108(12):2573–2581. doi: 10.1038/bjc.2013.250

Figure 3.

Figure 3

Kaplan–Meier survival curves for the DFS of PCa patients (A), low- and intermediate-recurrence risk PCa patients (B), intermediate-recurrence risk PCa patients (C) and high- and very high-recurrence risk PCa patients (D) comparing with miR-145 expression levels. P-value was calculated by ‘log-rank test'.